DAFNA CAPITAL MANAGEMENT LLC Cytokinetics, Incorporated Transaction History

DAFNA CAPITAL MANAGEMENT LLC portfolio value:

$8.91M
portfolio value

DAFNA CAPITAL MANAGEMENT LLC quarter portfolio value change:

+23.31%
quarter

Cytokinetics, Incorporated 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -13.00% -27.5K shares 605K $48.45 183.99K
Q2 2022 share 0.00% 0 shares 525K $39.29 211.49K
Q1 2022 share Increase +57.72% 77.40K shares 1.67M $36.81 211.49K
Q4 2021 share Decrease -23.37% -40.90K shares -143K $45.6 134.09K
Q3 2021 share Increase 0.00% 175K shares 6.25M $35.74 175K
Q1 2020 share Decrease -100.00% -418.72K shares -4.44M $11.79 0
Q4 2019 share 0.00% 0 shares -322K $10.61 418.72K
Q3 2019 share Decrease -12.25% -58.46K shares -603K $11.38 418.72K
Q2 2019 share Increase +19.21% 76.90K shares 2.13M $11.25 477.19K
Q1 2019 share Increase +115.41% 214.46K shares 2.06M $8.09 400.29K
Q4 2018 share Increase +196.42% 123.13K shares 557K $6.32 185.82K
Q3 2018 share Decrease -9.72% -6.74K shares 41K $9.85 62.69K
Q2 2018 share Increase 0.00% 69.43K shares 576K $8.3 69.43K
Q1 2017 share Decrease -100.00% -210.30K shares -2.55M $12.85 0
Q4 2016 share Increase +15.72% 28.56K shares 887K $12.15 210.30K
Q3 2016 share Increase +21.16% 31.73K shares 244K $9.18 181.73K
Q2 2016 share Increase +169.78% 94.4K shares 1.03M $9.49 150K
Q1 2016 share Increase +39.00% 15.6K shares -26K $7.05 55.6K